| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |